Actuate Therapeutics, Inc. Common stock (ACTU) is a publicly traded Healthcare sector company. As of May 21, 2026, ACTU trades at $2.51 with a market cap of $58.14M and a P/E ratio of -2.36. ACTU moved +3.33% today. Year to date, ACTU is -60.41%; over the trailing twelve months it is -76.32%. Its 52-week range spans $1.58 to $11.99. Analyst consensus is buy with an average price target of $13.50. Rallies surfaces ACTU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Actuate Therapeutics, Inc. Common stock (ACTU) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ACTU moved +3.33% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $2.51 |
| Market Cap | $58.14M |
| P/E Ratio | -2.36 |
| EPS | $-1.06 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.99 |
| 52-Week Low | $1.58 |
| Volume | 10 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-22.23M |
| Gross Margin | 0.00% |
2 analysts cover ACTU: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $13.50.